期刊文献+

临床分离主要革兰阴性杆菌分布及耐药性监测 被引量:11

Distribution and drug resistance of main gram-negative bacilli isolated from clinics
原文传递
导出
摘要 目的调查2009年医院临床分离主要革兰阴性杆菌的样本分布和耐药性,为临床医师合理用药提供参考。方法收集临床分离革兰阴性杆菌培养鉴定,采用纸片扩散法(K-B法)测定14种抗菌药物的敏感情况,用WHONET 5软件进行分析。结果 2009年共分离出革兰阴性菌1322株,前4位的是大肠埃希菌431株(32.60%),产超广谱β-内酰胺酶(ESBLs)率为47.56%;肺炎克雷伯菌266株(20.12%),产ESBLs发生率为30.45%;鲍氏不动杆菌224株(16.94%);铜绿假单胞菌140株(10.59%);主要革兰阴性杆菌对所有抗菌药物均产生一定的耐药性。结论医院感染的耐药性十分严重,医院应加强监测与控制;临床医师应在经验用药前关注目前细菌的耐药情况正确选用抗菌药物。 OBJECTIVE To investigate the distribution and antibiotic resistance of the main Gram-negative bacillus isolated from our hospital in 2009 and offer suggestions for clinic. METHODS Gram-negative bacilli were cultured by routine methods. The antibiotic susceptibilities to 14 kinds of antibiotics were tested By K-B method and analyzed by Whonet software. RESULTS There were 1322 G- Bacillus isolated from Clinical specimens and the top four of them were 431 Escherichia coli (E. coli), 266 Klebsiella pneumoniae (KPN), 224 Acinetobacter baumannii(ABA), 140 Pseudomonas aeruginosa (PAE). The detection rate of ESBLs-producing E. coli was 47. 56 and that of KPN was 30.45%. The resistance 14 kinds of antibiotics to were in varying degrees in the four bacilli. CONCLUSIONS Drug resistance status of pathogens in nosocomial infections to antibiotics is very serious. The monitoring and controlling should be strengthened. Clinicians should rationally choose antibiotics before experimental medication according to the drug resistance of the bacillus.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第5期986-988,共3页 Chinese Journal of Nosocomiology
关键词 医院感染 革兰阴性杆菌 抗菌药物 耐药性监测 Nosocomial infection Gram-negative bacillus Antibiotics Resistance surveillance
  • 相关文献

参考文献10

二级参考文献66

共引文献574

同被引文献84

  • 1刘爱萍,陈如,桂清荣.呼吸内科临床分离细菌耐药性监测[J].华中科技大学学报(医学版),2003,32(4):451-453. 被引量:4
  • 2许小敏,陈琳,赵伟和,叶振悦.阴沟肠杆菌耐药性的检测与分析[J].中华医院感染学杂志,2006,16(3):343-344. 被引量:13
  • 3高劲松,束宝红.236例尘肺病人死因分析[J].中国职业医学,2006,33(6):483-484. 被引量:7
  • 4熊自忠,李涛,徐元宏,等.3株含qnr基因肺炎克雷伯菌中超光谱β-内酰胺酶的检测[J].中国药理通报,2006,22(3):325-328. 被引量:1
  • 5National Committee for Clinical Laboratory standards. Performance standards for antimicrobial susceptibility tests [J]. NCCLS, 2001, 21 (1): 40-45. 被引量:1
  • 6Jacoby GA, Han E Detection of extended-spectrum beta-lactamases in clinical isolates of ldebsieUa pneumoniae and Escherichia coli [J]. J Cli Microbiol, 1996, 34(4): 908-911. 被引量:1
  • 7Clinical and Laboratory Standards Institute. Perform- ance standards for antimicrobial susceptibility testing; Twentieth informational supplement[S]. CLSI docu- ments M100-S20, Wayne, PA: 2010. 被引量:1
  • 8刘晓莉,黄云昆,单斌,等.2010年昆明地区细菌耐药性监测及分析[J].实验与临床医学,2011,29(2):113-116. 被引量:1
  • 9Clinical and Laboratory Standard Institute. MIO0 $20 Perform ante standards for antimicrobial susceptibility testing twentieth informational supplement[S. Wayne Pennsylvania CLSI, 2010 100. 被引量:1
  • 10Mori D,Yano K,Tsubota K,et al. Simulsion of platelet adhension and aggergation regulated by fibrinogen and von Willebrand factor [J. Thromb Haemost,2008,99(1) :108-115. 被引量:1

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部